Rockefeller Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $210M | Buy |
427,331
+4,351
| +1% | +$2.36M | 0.37% | 51 |
|
|
2025
Q4 | $245M | Buy |
422,980
+84,122
| +25% | +$47.6M | 0.44% | 32 |
|
|
2025
Q3 | $164M | Buy |
338,858
+9,301
| +3% | +$4.33M | 0.32% | 54 |
|
|
2025
Q2 | $134M | Sell |
329,557
-14,298
| -4% | -$5.98M | 0.29% | 64 |
|
|
2025
Q1 | $171M | Buy |
343,855
+55,021
| +19% | +$29.8M | 0.42% | 36 |
|
|
2024
Q4 | $150M | Buy |
288,834
+43,983
| +18% | +$24.2M | 0.39% | 43 |
|
|
2024
Q3 | $151M | Buy |
244,851
+1,966
| +0.8% | +$1.16M | 0.41% | 44 |
|
|
2024
Q2 | $134M | Buy |
242,885
+14,768
| +6% | +$8.46M | 0.38% | 50 |
|
|
2024
Q1 | $133M | Buy |
228,117
+20,293
| +10% | +$11.4M | 0.39% | 47 |
|
|
2023
Q4 | $110M | Buy |
207,824
+216
| +0.1% | +$105K | 0.37% | 56 |
|
|
2023
Q3 | $105M | Buy |
207,608
+8,053
| +4% | +$4.29M | 0.41% | 47 |
|
|
2023
Q2 | $103M | Buy |
199,555
+24,240
| +14% | +$13.1M | 0.4% | 46 |
|
|
2023
Q1 | $101M | Sell |
175,315
-7,101
| -4% | -$4M | 0.43% | 42 |
|
|
2022
Q4 | $100M | Sell |
182,416
-5,106
| -3% | -$2.71M | 0.5% | 37 |
|
|
2022
Q3 | $95.1M | Buy |
187,522
+11,083
| +6% | +$6.2M | 0.49% | 39 |
|
|
2022
Q2 | $95.9M | Buy |
176,439
+17,721
| +11% | +$9.75M | 0.51% | 37 |
|
|
2022
Q1 | $93.7M | Buy |
158,718
+11,961
| +8% | +$6.87M | 0.45% | 44 |
|
|
2021
Q4 | $97.9M | Buy |
146,757
+7,624
| +5% | +$4.76M | 0.46% | 43 |
|
|
2021
Q3 | $79.5M | Buy |
139,133
+18,917
| +16% | +$10.4M | 0.42% | 47 |
|
|
2021
Q2 | $60.6M | Buy |
120,216
+24,682
| +26% | +$11.6M | 0.34% | 62 |
|
|
2021
Q1 | $43.6M | Buy |
95,534
+11,006
| +13% | +$5.25M | 0.3% | 75 |
|
|
2020
Q4 | $39.4M | Buy |
84,528
+20,106
| +31% | +$9.43M | 0.3% | 80 |
|
|
2020
Q3 | $28.4M | Buy |
64,422
+7,258
| +13% | +$3M | 0.27% | 95 |
|
|
2020
Q2 | $20.7M | Buy |
57,164
+7,790
| +16% | +$2.61M | 0.22% | 104 |
|
|
2020
Q1 | $14M | Buy |
49,374
+6,554
| +15% | +$2.07M | 0.18% | 119 |
|
|
2019
Q4 | $13.9M | Sell |
42,820
-6,490
| -13% | -$1.97M | 0.17% | 124 |
|
|
2019
Q3 | $14.4M | Buy |
49,310
+1,432
| +3% | +$410K | 0.19% | 106 |
|
|
2019
Q2 | $14.1M | Buy |
47,878
+8,690
| +22% | +$2.39M | 0.2% | 99 |
|
|
2019
Q1 | $10.7M | Buy |
39,188
+14,001
| +56% | +$3.48M | 0.15% | 112 |
|
|
2018
Q4 | $5.64M | Buy |
25,187
+4,121
| +20% | +$967K | 0.1% | 127 |
|
|
2018
Q3 | $5.14M | Buy |
21,066
+1,296
| +7% | +$298K | 0.08% | 123 |
|
|
2018
Q2 | $4.09M | Buy |
19,770
+375
| +2% | +$79.6K | 0.07% | 130 |
|
|
2018
Q1 | $4M | Buy |
+19,395
| New | +$4.07M | 0.07% | 135 |
|
Other funds holding TMO
VCM
Rockefeller Capital Management's TMO Position: Q1 2026 in Review
Rockefeller Capital Management increased its Thermo Fisher Scientific (TMO) stake by 1% in Q1 2026, buying an estimated $2.36M and bringing the position to 427,331 shares worth $210M. The position accounts for 0.37% of the portfolio, ranked #51.
Rockefeller Capital Management first reported a position in TMO in Q1 2018 and has held it in 33 quarters since. The position peaked at $245M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Rockefeller Capital Management held 427,331 shares of Thermo Fisher Scientific worth $210M as of Q1 2026.
- Rockefeller Capital Management bought 4,351 Thermo Fisher Scientific shares in Q1 2026, an estimated $2.36M.
- Thermo Fisher Scientific made up 0.37% of Rockefeller Capital Management's portfolio in Q1 2026, its #51 holding.
- Rockefeller Capital Management first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 33 quarters since.
- Rockefeller Capital Management's Thermo Fisher Scientific position peaked at $245M in Q4 2025.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.